EE+ POEM Archive
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Patent Foramen Ovale Closure in Cryptogenic Stroke Reduces Recurrence Rate Compared With Antiplatelet Agents." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents.
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents. Accessed January 30, 2025.
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
Patent Foramen Ovale Closure in Cryptogenic Stroke Reduces Recurrence Rate Compared With Antiplatelet Agents [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 January 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
ID - 1314366
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
